Physician profile
John J Rush
NPI 1851337281
$1,745.68
in general payments reported to CMS, 2019-2025
9 companies · $1,456 in 2025
The $1,456 reported for 2025 was more than what 96% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.90 · 2021: $67.83 · 2022: $133 · 2023: $33.96 · 2024: $38.79 · 2025: $1,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,094 · Food and Beverage: $434.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,094.35 |
| Food and Beverage | $434.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medline Industries Lp | $1,375.65 | 2025 | |
| Avanos Medical | $84.02 | 2022 | |
| Channel-Markers Medical LLC | $80.43 | 2025 | Genvisc 850 Sodium Hyaluronate |
| Fidia Pharma USA INC. | $58.88 | 2021-2024 | Hyalgan, Hymovis, Triluron |
| Orthogenrx INC. | $47.76 | 2021 | |
| Siemens Medical Solutions USA, INC. | $33.96 | 2023 | Embozene |
| Ferring Pharmaceuticals INC. | $30.35 | 2022 | |
| Depuy Synthes Sales INC. | $18.73 | 2024 | Monovisc, Orthovisc |
| Pacira Therapeutics, INC. | $15.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Rush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.